The Boston Society Medical Symposium on Acute Myeloid Leukemia (AML) - Virtual Event
October 22, 2021

Confirmed Speakers :

PLENARY SPEAKER

Reimagining Medicine to Bring New Therapies for our Patients

Vas Narasimhan, MD, MPP

CEO, Novartis

Basel, Switzerland

 

Manipulating the Microenvironment for AML Therapies (GMI 1271)

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia,

Dana Farber Cancer Institute

Professor of Medicine,

Harvard Medical School

Update in CAR-T and Other Cell Therapies for AML

Gail J. Roboz, MD

Professor of Medicine & Director

Clinical Translational Leukemia Program

Weill Medical College, Cornell University

FDA Perspective on New Therapy Development for AML

Lori A. Ehrlich, MD, PhD

Medical Officer, DHHS/CDER

Food and Drug Administration (FDA)

Immunomodulatory Therapeutic Strategies (PD1/PDL1, CD47, CD70)

David Sallman, MD

Assistant Member

Department of Malignant Hematology

Moffitt Cancer Center & Research Institute

Targeted Therapy for Pediatric AML

Yana Pikman, MD

Attending Physician, Pediatric Heme/Onc.

Dana Farber Cancer Institute

Harvard Medical School

From Disney to Doxorubicin: Childhood Cancer Perspective from a Medical Dad

Andrew J. Herber, PA-C

Mayo Clinic Hospital

SARS-CoV-2 Infections in Malignancy

Vivek Naranbhai, MD, PhD

Clinical Fellow in Medicine

Dana Farber Cancer Institute

 

Updates in MDS Treatment

Andrew M. Brunner, MD

Asst. Professor, Harvard Medical School

Assistant, Center for Leukemia

Massachusetts General Hospital

Transplant in the Contest of MDS Patients

Corey Cutler, MD, MPH, FRCPC

Medical Director, Adult Stem Cell Transplantation Program

Director Clinical Research, Stem Cell Transplantation

Associate Professor of Medicine, Harvard Medical School

Invited Speakers for 2021

Richard M. Stone, MD, Director of the Adult Acute Leukemia Program @ DFCI

Jacalyn Mara Rosenblatt, MD, Associate Professor of Medicine, Beth Israel Deaconess Medical Center

Rizwan Romee, MD, Director, Haploidentical Donor Transplantation Program, Associate Professor of Medicine, Harvard Medical School, DFCI

Geoffrey Uy, MD, Associate Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine, Siteman Cancer Center

Jacqueline Garcia, MD, DFCI, Instructor of Medicine, Harvard Medical School

Christopher J. Gibson, MD, Instructor of Medicine, Harvard Medical School, DFCI

Karin M. Gaensler, MD, Chair, Hematological Malignancies, Univ. of California, San Francisco

 

 AML 2021 Sessions 

Session I:  The Current Landscape - Updates

Session II:  State of the Art Research and Treatment Options - Updates

Session III:  On the Horizon

 

 

 Join our Linkedin Group:

Sessions

Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon

Registration

Click here to register for the AML 2021 conference online.

AML 2021 will be fully virtual

October 22, 2021

 

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy